“Cabozantinib-Exposed Renal Cell Carcinoma Organoids Suggest Transcriptomic Associations with Treatment Resistance in Clear Cell and Nonclear Cell Tumors” (2025) Journal of Kidney Cancer, 12(2), pp. 37–45. doi:10.15586/jkcvhl.v12i2.386.